Technology
Pre Neurolab Laboratory, a subsidiary of Pre Diagnostics AS, specializes in providing analytical biomarker services primarily focused on neurodegenerative diseases. Established in 2022 with a state-of-the-art laboratory located in Oslo, Norway, we are equipped to support a wide range of research biomarker studies using our advanced immunoassay platforms. Our services can accommodate studies involving sample sizes ranging from 50 to several thousands.
Service portfolio
Pre Neurolab’s portfolio is focused on biomarkers within neurodegenerative diseases. Below please find our standard biomarker offering that we run in our laboratory. On request we also have the possibility to set up other biomarkers and run them in our laboratory
Tauopathies and Amyloidosis
Other Biomarkers
Inflammation
Technology
PreDx is an expert provider of analytical services based on MSD™ digital immunoassay platform. We have deep experience with running 100s of research samples as well as developing sensitive homebrew immunoassays through many years.
MESO Quickplex from MesoScale Discoveries is an immunoassay-based platform that utilizes high binding carbon electrodes and electro chemiluminescence detection. This is a more sensitive and versatile alternative to a conventional ELISA.
Additionally, we have access to various analytical immunoassay instruments from Quanterix and Thermo Fisher Scientific supplementing our own laboratory capabilities.
Quality
All research samples are analyzed in Pre Diagnostics facilities that work according to ISO 13485. A QMS system is implemented. Moreover, the following applies
All work is carried out following SOPs
All personnel are trained for the analysis and procedures they perform
All analytical methods can be experimentally validated according to customer purpose of use
Only high-quality reagents with Certificate of analysis (CoA) are used
All instruments used are qualified and calibrated
Who are we?
Our Laboratory management consists of Laboratory Director Line Amundsen and Chief Medical Office Erik Christensen MD PhD
Laboratory Director
Line Amundsen
Line holds a master`s degree in chemistry from the University of Bergen. She has many years of experience from working in an ISO-certified clinical laboratory at Haukeland University Hospital in Oslo in addition to several years working in the industry. She has a wide experience in developing and validating immunoassays for clinical use.
CMO and Co-founder
Erik Christensen
Christensen has 30+ years of experience from the diagnostics industry, including as CEO of diagnostic company DiaGenic ASA, as Nordic Medical Director subsequently as Country Manager for Abbott’s Diagnostic division in Norway. He has extensive experience from clinical practice, serving as senior consultant in Clinical Chemistry at Rikshospitalet and Ullevål University Hospital, holds a medical degree from Odense University, and earned his PhD peroxisomal ß-oxidation of fatty acids from the University of Oslo. He is a certified Clinical Pathologists by the Norwegian Medical Association and is a longstanding advisor to the Norwegian Research Council.